लोड हो रहा है...
Chimeric antigen receptor T cell therapy for multiple myeloma
Chimeric antigen receptor (CAR) T cell therapy is a new cancer immunotherapy targeting cancer-specific cell surface antigen. CD19-CAR T cells have been already shown to be very effective to B cell leukemia/lymphoma. Now, many researchers are developing CAR T cells for multiple myeloma. CAR T cells t...
में बचाया:
| में प्रकाशित: | Inflamm Regen |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BioMed Central
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6547554/ https://ncbi.nlm.nih.gov/pubmed/31171941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41232-019-0100-6 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|